de Liefde II, van der Klift M, de Laet CE, van Daele PL, Hofman A, Pols HA (2005) Bone mineral density and fracture risk in type-2 diabetes mellitus: the Rotterdam Study. Osteoporos Int 16(12):1713–1720

Article  PubMed  Google Scholar 

Betteridge DJ (2011) Thiazolidinediones and fracture risk in patients with Type 2 diabetes. Diabet Med 28(7):759–771

Article  CAS  PubMed  Google Scholar 

Hu J, Han J, Jin M, Jin J, Zhu J (2023) Effects of metformin on bone mineral density and bone turnover markers: a systematic review and meta-analysis. BMJ Open 13(6):e072904

Article  PubMed  PubMed Central  Google Scholar 

Blau JE, Taylor SI (2018) Adverse effects of SGLT2 inhibitors on bone health. Nat Rev Nephrol 14(8):473–474

Article  CAS  PubMed  PubMed Central  Google Scholar 

Nauck MA, Meier JJ (2018) Incretin hormones: their role in health and disease. Diabetes Obes Metab 20(Suppl 1):5–21

Article  CAS  PubMed  Google Scholar 

ElSayed NA, Aleppo G, Aroda VR, Bannuru RR, Brown FM, Bruemmer D, Collins BS, Hilliard ME, Isaacs D, Johnson EL, Kahan S, Khunti K, Leon J, Lyons SK, Perry ML, Prahalad P, Pratley RE, Seley JJ, Stanton RC, Gabbay RA, on behalf of the American Diabetes Association. 9 (2023) Pharmacologic approaches to glycemic treatment: standards of care in diabetes-2023. Diabetes Care 46(Suppl 1):S140–S157

Article  CAS  PubMed  Google Scholar 

Nuche-Berenguer B, Moreno P, Esbrit P, Dapía S, Caeiro JR, Cancelas J, Haro-Mora JJ, Villanueva-Peñacarrillo ML (2009) Effect of GLP-1 treatment on bone turnover in normal, type 2 diabetic, and insulin-resistant states. Calcif Tissue Int 84(6):453–461

Article  CAS  PubMed  Google Scholar 

Cheng Y, Liu P, Xiang Q, Liang J, Chen H, Zhang H, Yang L (2022) Glucagon-like peptide-1 attenuates diabetes-associated osteoporosis in ZDF rat, possibly through the RAGE pathway. BMC Musculoskelet Disord 23(1):465

Article  CAS  PubMed  PubMed Central  Google Scholar 

Viggers R, Rasmussen NH, Vestergaard P (2023) Effects of Incretin Therapy on Skeletal Health in Type 2 Diabetes-A Systematic Review. JBMR Plus 7(11):e10817

Article  CAS  PubMed  PubMed Central  Google Scholar 

Eminov E, Hortu I, Akman L, Erbas O, Yavasoglu A, Cirpan T (2018) Exenatide preserves trabecular bone microarchitecture in experimental ovariectomized rat model. Arch Gynecol Obstet 297(6):1587–1593

Article  CAS  PubMed  Google Scholar 

Zhou Y, Xue X, Guo Y, Liu H, Hou Z, Chen Z, Wang N, Li F, Wang Y (2021) A quinoxaline-based compound ameliorates bone loss in ovariectomized mice. Exp Biol Med (Maywood) 246(23):2502–2510

Article  CAS  PubMed  Google Scholar 

Conversano F, Franchini R, Greco A, Soloperto G, Chiriacò F, Casciaro E, Aventaggiato M, Renna MD, Pisani P, Di Paola M, Grimaldi A, Quarta L, Quarta E, Muratore M, Laugier P, Casciaro S (2015) A novel ultrasound methodology for estimating spine mineral density. Ultrasound Med Biol 41(1):281–300

Article  PubMed  Google Scholar 

Di Paola M, Gatti D, Viapiana O, Cianferotti L, Cavalli L, Caffarelli C, Conversano F, Quarta E, Pisani P, Girasole G, Giusti A, Manfredini M, Arioli G, Matucci-Cerinic M, Bianchi G, Nuti R, Gonnelli S, Brandi ML, Muratore M, Rossini M (2019) Radiofrequency echographic multispectrometry compared with dual X-ray absorptiometry for osteoporosis diagnosis on lumbar spine and femoral neck. Osteoporos Int 30(2):391–402

Article  PubMed  Google Scholar 

Caffarelli C, Tomai Pitinca MD, Al Refaie A, Ceccarelli E, Gonnelli S (2022) Ability of radiofrequency echographic multispectrometry to identify osteoporosis status in elderly women with type 2 diabetes. Aging Clin Exp Res 34(1):121–127

Article  PubMed  Google Scholar 

Starup-Linde J, Eriksen SA, Lykkeboe S, Handberg A, Vestergaard P (2014) Biochemical markers of bone turnover in diabetes patients-a meta-analysis, and a methodological study on the effects of glucose on bone markers. Osteoporos Int 25(6):1697–1708

Article  CAS  PubMed  Google Scholar 

Eller-Vainicher C, Cairoli E, Grassi G, Grassi F, Catalano A, Merlotti D, Falchetti A, Gaudio A, Chiodini I, Gennari L (2020) Pathophysiology and Management of Type 2 diabetes mellitus bone fragility. J Diabetes Res 22(2020):7608964

Google Scholar 

Wu B, Fu Z, Wang X, Zhou P, Yang Q, Jiang Y, Zhu D (2022) A narrative review of diabetic bone disease: characteristics, pathogenesis, and treatment. Front Endocrinol (Lausanne) 13:1052592

Article  PubMed  Google Scholar 

Hygum K, Starup-Linde J, Harsløf T, Vestergaard P, Langdahl BL (2017) Mechanisms in endocrinology: diabetes mellitus, a state of low bone turnover - a systematic review and meta-analysis. Eur J Endocrinol 176(3):R137–R157

Article  CAS  PubMed  Google Scholar 

Meng J, Ma X, Wang N, Jia M, Bi L, Wang Y, Li M, Zhang H, Xue X, Hou Z, Zhou Y, Yu Z, He G, Luo X (2016) Activation of GLP-1 receptor promotes bone marrow stromal cell osteogenic differentiation through β-catenin. Stem Cell Reports 6(4):579–591

Article  CAS  PubMed  PubMed Central  Google Scholar 

Iepsen EW, Lundgren JR, Hartmann B, Pedersen O, Hansen T, Jørgensen NR, Jensen JE, Holst JJ, Madsbad S, Torekov SS (2015) GLP-1 receptor agonist treatment increases bone formation and prevents bone loss in weight-reduced obese women. J Clin Endocrinol Metab 100(8):2909–2917

Article  CAS  PubMed  Google Scholar 

Hygum K, Harsløf T, Jørgensen NR, Rungby J, Pedersen SB, Langdahl BL (2020) Bone resorption is unchanged by liraglutide in type 2 diabetes patients: a randomised controlled trial. Bone 132:115197

Article  CAS  PubMed  Google Scholar 

Cai TT, Li HQ, Jiang LL, Wang HY, Luo MH, Su XF, Ma JH (2021) Effects of GLP-1 receptor agonists on bone mineral density in patients with type 2 diabetes mellitus: a 52-week clinical study. Biomed Res Int 17(2021):3361309

Google Scholar 

Huang CF, Mao TY, Hwang SJ (2023) The effects of switching from dipep tidyl Peptidase-4 inhibitors to glucagon-like Peptide-1 receptor agonists on bone mineral density in diabetic patients. Diabetes Metab Syndr Obes 16:31–36

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zibellini J, Seimon RV, Lee CM, Gibson AA, Hsu MS, Shapses SA, Nguyen TV, Sainsbury A (2015) Does diet-induced weight loss lead to bone loss in overweight or obese adults? A systematic review and meta-analysis of clinical trials. J Bone Miner Res 30(12):2168–2178

Article  CAS  PubMed  Google Scholar 

Herrou J, Mabilleau G, Lecerf JM, Thomas T, Biver E, Paccou J (2024) Narrative review of effects of glucagon-like peptide-1 receptor agonists on bone health in people living with obesity. Calcif Tissue Int 114(2):86–97

Article  CAS  PubMed  Google Scholar 

Zhang YS, Zheng YD, Yuan Y, Chen SC, Xie BC (2021) Effects of anti-diabetic drugs on fracture risk: a systematic review and net work meta-analysis. Front Endocrinol (Lausanne) 14(12):735824

Article  Google Scholar 

Trandafir AI, Sima OC, Gheorghe AM, Ciuche A, Cucu AP, Nistor C, Carsote M (2023) Trabecular bone score (TBS) in individuals with type 2 diabetes mellitus: an updated review. J Clin Med 12(23):7399

Article  CAS  PubMed  PubMed Central  Google Scholar 

Armamento-Villareal R, Sadler C, Napoli N, Shah K, Chode S, Sinacore DR, Qualls C, Villareal DT (2020) Weight loss in obese older adults increases serum sclerostin and impairs hip geometry but both are prevented by exercise training. J Bone Miner Res 27(5):1215–1221

Article  Google Scholar 

Yang J, Park O-J, Kim J, Han S, Yang Y, Yun C-H, Han SH (2019) Adiponectin deficiency triggers bone loss by up-regulation of osteoclastogenesis and down-regulation of osteoblastogenesis. Front Endocrinol 10:815

Article  Google Scholar 

Simental-Mendía LE, Sánchez-García A, Linden-Torres E, Simental-Mendía M (2021) Impact of glucagon-like peptide-1 receptor agonists on adiponectin concentrations: a meta-analysis of randomized controlled trials. Br J Clin Pharmacol 87(11):4140–4149

Article  PubMed  Google Scholar 

Biver E, Salliot C, Combescure C, Gossec L, Hardouin P, Legroux-Gerot I, Cortet B (2011) Influence of adipokines and ghrelin on bone mineral density and fracture risk: a systematic review and meta-analysis. J Clin Endocrinol Metab 96(9):2703–2713